Drug development and clinical trials – preclinical tests, phases, placebo and double-blind trials
BiologyHealth & DiseaseAges 16–17Virtual lab
How do you mainly use this simulation?
Use it with your class: students open it from a link or a QR code, with no account needed.
Take six made-up candidate compounds through tests on cells and animals and then phase 1, 2 and 3 clinical trials to a licence, and see where and why each one is stopped. Design your own trials of three made-up drugs: choose the sample size, the control group and the blinding, then compare the measured effect and its 95% confidence interval to see how bias and sample size change the result. A card sort separates painkillers from antibiotics.
Lesson: Discovery and development of drugs: clinical trials
What it shows
A new medicine is tested first in the laboratory, on cells, tissues and live animals, for toxicity, efficacy and dose. Clinical trials follow: a few healthy volunteers in phase 1 for safety, then patients in phases 2 and 3 to see whether it works and which dose is best. A fair trial compares the drug with a placebo and is double-blind, so expectations cannot bias the result, and a larger trial gives a narrower confidence interval. The candidates, drugs and effect sizes here are made up for learning.
How to use
On From lab to licence, pick a Candidate and press Next stage until it is stopped or licensed. On Design a trial, choose the Drug, Patients in each group, Control group and Blinding, then press Run the trial or +20 trials and read the measured effect and its interval. On Painkillers or antibiotics?, put each card in a box and press Check.
Parameters you can change
- Screen From lab to licence, Design a trial, Painkillers or antibiotics?
- Candidate compound Candidate 1, Candidate 2, Candidate 3, Candidate 4, Candidate 5, Candidate 6
- Drug Drug A, Drug B, Drug C
- Patients in each group 10–2000
- Control group None, No treatment, Placebo
- Blinding Open (nobody blinded), Single-blind, Double-blind
Questions to explore
- Why does a fair trial give the control group a placebo instead of no treatment at all?
- How does the width of the 95% confidence interval change when you use four times as many patients?
- Why can a drug with no real effect sometimes look effective in a well-designed trial?